Almost there! Just a few clicks from the resource you need.
You can either checkout with the notes in your basket now, or find more notes. The choice is yours!
My Basket
Kotter’s Change Model (Step 7 and 8) in Genetic Testing in Chronic Pain Patients
Genetic Testing in Chronic Pain Patients Stage 7 & 8 Standard pain medications need activation by the CYP2D6 enzyme to become effective. Roughly half of patients possess genes that alter the function of the CYP2D6 enzyme. Testing for the gene alterations allows the physician to make changes to the dosage regimens so as to cater for the altered metabolisms, which optimizes the efficacy and safety of pain medications.
£37.50 Preview Remove